ZyVersa Therapeutics’ CEO, Stephen C. Glover, Is an Invited
ZyVersa is advancing a dynamic pipeline of drug candidates with multiple programs built around two proprietary technologies – Phase 2a ...
Read moreZyVersa is advancing a dynamic pipeline of drug candidates with multiple programs built around two proprietary technologies – Phase 2a ...
Read more3 July 2024 - The International Olympic Committee (IOC) has today published an update to the list of the Individual ...
Read more28 June 2024 - The International Olympic Committee (IOC) has today published an update to the list of the Individual Neutral ...
Read more27 June 2024 - The International Olympic Committee (IOC) has today published an update to the list of the Individual Neutral ...
Read moreVancouver, BC, June 07, 2024 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a Burnaby-based clinical-stage biotechnology company, is pleased to announce ...
Read moreMINNEAPOLIS, March 22, 2024 (GLOBE NEWSWIRE) -- Following months of collaboration with Broadcom, VMware, and the community, Atomic Data is ...
Read moreColorado Spring, Colorado, Jan. 19, 2024 (GLOBE NEWSWIRE) -- KODDPA Corporation, a professional AI quantitative trading company, is honored to ...
Read moreFollowing a recommendation by the International Olympic Committee (IOC)'s Future Host Commission for the Olympic Winter Games, the IOC Executive Board (EB) today ...
Read more© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.
© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.